This interaction, mediated by the carboxyl-terminal PBM of PTEN and PDZ domain 2 of Dlg1 [55], [56], enhances PTEN activity to block proliferation and viability of MCF-7 breast carcinoma cells and to suppress Schwann cell myelination of peripheral nerves [57], [58]. Here, DLG1 is linked to breast carcinoma.